Neuroimmune Foundation is a 501(c)(3) non-profit organization dedicated to
  • dramatically accelerating physician education of immunopsychiatric conditions
  • significantly improving outcomes for individuals impacted by these disorders through prompt diagnosis and insurance based care
  • providing meaningful support to families during their darkest days
  • catalyzing research at an unprecedented pace that will ultimately lead to lasting remission for all individuals impacted by these disorders.
Join our next ECHO cohort!

Psychiatric Presentations with a Neuroimmune Basis ECHO

A comprehensive educational model designed to equip physicians to evaluate and treat children, youth, and adults with psychiatric symptoms due to an underlying neuroimmune condition (examples: encephalitis, neuropsychiatric lupus, PANS, Sydenham’s Chorea).

One-hour weekly meetings featuring short didactics by subject matter experts from leading university programs followed by case presentations.

We invite you to take advantage of and support our ever-growing network of knowledgeable clinicians. There is no cost for physicians to join.

Join a two day conference via webinar!

Inflamma­tory Brain Disorders Conference 2026

The 2026 Inflammatory Brain Disorders Conference is hosted by Neuroimmune Institute, in partnership with Neuroimmune Foundation and with our Stanford, UCSF, and USYD collaborators. Neuroimmune Institute was founded with the goal of rapidly advancing clinical medicine and research focused on immunopsychiatric, neuroimmune, and inflammatory brain conditions as well as autism.

Neuroimmune Institute offers continuing medical education on a broad array of topics beyond the scope of Neuroimmune Foundation’s mission.

Discover our new PTEC © Tool!

PANS/PANDAS Treatment and Evaluation Checklist (PTEC ©)

PANS/PANDAS/Related Inflammatory Brain Disorders Treatment and Flare Evaluation Checklist (PTEC)

In August 2025 we launched our validated digital tool (see study) that allows patients and families to track symptoms of PANS, PANDAS, and related inflammatory brain conditions and share the results with their healthcare providers. This tool is intended to be shared with clinicians, creating a clear, objective picture of symptom progression that can inform treatment decisions and care planning.

What are Inflammatory Brain Disorders?

Individuals with inflammatory brain conditions often present with prominent neuropsychiatric symptoms that can be confusing for physicians and families alike. Our CME events feature nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

Check out our

Extensive Free Resources

Our extensive free resources for clinicians include Continuing Medical Education, access to top experts in the field through monthly case consultations, and quarterly compilation of relevant research. We provide clinicians the tools to confidently diagnose and treat immune-mediated neuropsychiatric illnesses and inflammatory brain conditions. Our Circle of Clinicians helps families to find a physician. Families are supported through therapist, physician, and researcher led webinars, local support meetings in locations around the world, a private Facebook group, and other resources.

Advocating on Behalf of Individuals with Neuroimmune and Inflammatory Brain Conditions

About us

Neuroimmune FoundationTogether with our supporters, Neuroimmune Foundation is making huge strides in educating clinicians on how to diagnose and treat immune and inflammation driven causes of psychiatric deteriorations. Visit our Impact Report pages to learn how our CME and related events help physicians gain confidence treating PANS, PANDAS, encephalitis, and related conditions.

Check out our Impact Reports: 

Sign up for our newsletter

  • (All fields required)

Support our work – with confidence!

Candid (formerly Guidestar), the world’s largest source of information on nonprofit organizations has granted Neuroimmune Foundation their Platinum Seal of Approval the past seven years in a row (2019–2025), an honor held by only 0.5% of nonprofits.

Neuroimmune Foundation is the only PANS-focused nonprofit to receive Charity Navigator‘s highest rating, 4/4 stars with a 100% rating.

Check the Neuroimmune Foundation's status at Guidestar.org
Check the Neuroimmune Foundation's status at Charity Navigator

Research Roundup

  • Neuropsychiatric Associations of Mast Cell Activiation Syndrome and its Implications with Mental Health and Depression

    Research Gate
    October 1, 2025

  • Epigenetic, Ribosomal, and Immune Dysregulation in Paediatric Acute-Onset Neuropsychiatric Syndrome

    Nature | Molecular Psychiatry
    August 30, 2025

  • Single-Cell RNA Seq in Sydenham Chorea Shows B Cell HLA-DR/DQ Upregulation and Plasma Cell Proteasomal Activation

    Annals of Clinical and Translational Neurology
    August 26, 2025

  • The Immune/Inflammatory Underpinnings of Neurodevelopmental Disorders and Pediatric Acute-Onset Neuropsychiatric Syndrome: A Scoping Review

    MDPI
    August 11, 2025

  • Validation of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)-Related Pediatric Treatment Evaluation Checklist (PTEC)

    MDPI
    July 28, 2025

  • Association of Viral RNAs in the Choroid Plexus with Bipolar Disorder and Schizophrenia and Evidence for the Hepatitis C Virus Involvement in Neuropathology

    PubMed.gov
    July 14, 2025

  • REM Sleep Atonia in Patients with Pediatric Acute-Onset Neuropsychiatric Syndrome: Implications for Pathophysiology

    Journal of Clinical Sleep Medicine
    May 1, 2025

  • Pediatric Post-infectious Neuroinflammatory Syndromes Come to the Fore

    Karger Developmental Neuroscience
    April 26, 2025

  • Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions

    Nature | Molecular Psychiatry
    April 25, 2025